Difference between revisions of "Hirvonen H, et al. Leuk. Lymphoma (1993) cited as Ref 118 in DOI: 10.1038/s41392-020-0110-5 (Q9381)"
Jump to navigation
Jump to search
(Created claim: Page(s) (P105): 197-205, #quickstatements; #temporary_batch_1590074839150) |
(Created claim: Fourth Author string (P152): Pelliniemi TT, #quickstatements; #temporary_batch_1590155310798) |
||
| Property / Fourth Author string | |||
| + | Pelliniemi TT | ||
| Property / Fourth Author string: Pelliniemi TT / rank | |||
| + | Normal rank | ||
Revision as of 13:49, 22 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Hirvonen H, et al. Leuk. Lymphoma (1993) cited as Ref 118 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Hirvonen H
0 references
Hukkanen V
0 references
Salmi TT
0 references
1993
0 references
Leuk. Lymphoma
0 references
11
0 references
L-myc and N-myc in hematopoietic malignancies (English)
0 references
197-205
0 references
Pelliniemi TT
0 references
